BMI vs CGNX
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
BMI
CGNX
Investment Advisor Scores
CGNX
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BMI | CGNX | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 31.5457 | 29.4985 | CGNX |
| PEG Ratio | 3.6866 | 2.7121 | CGNX |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 0.1% | 13.2% | CGNX |
| Earnings Growth | 4.2% | 400.0% | CGNX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 36.5/100 | 56.2/100 | CGNX |
| Profit Margin | 14.4% | 21.5% | CGNX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | BUY | CGNX |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BMI
MarkupPrice above SMA50, rising 50-day trend (4.3% over 20 days), RSI 62
CGNX
MarkdownPrice below a falling SMA50 (slope -5.3%), weak momentum, RSI 42
Fundamentals Snapshot
| Metric | BMI | CGNX |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 31.8 | 25.6 |
| Trailing P/E | 36.4 | 35.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.4% | 0.7% |
| Operating Margin | 0.2% | 0.3% |
| EPS | 4.33 | 1.43 |
| Dividend Yield | 0.01% | 0.01% |